Moderna President Says All Vaccines’ Efficacy May Struggle Against Omicron

Three vials of the "Moderna COVID-19 Vaccine" at a new COVID-19 vaccination center at the "Velodrom" (velodrome-stadium) in Berlin, Germany, on Feb. 17, 2021. Michael Sohn/Pool/Getty Images

Moderna President Stephen Hoge said there is a risk that existing COVID-19 shots may struggle in their effectiveness against the Omicron variant, though it’s too early to say by how much.

Hoge’s comments follow those of Moderna’s Chief Executive Officer Stéphane Bancel, who said last week that he predicts current vaccines will be far less effective against the latest CCP (Chinese Communist Party) virus variant due to the high number of mutations on the spike protein.